6 research outputs found
An embryonic-specific repressor element located 3 ` to the (A)gamma-globin gene influences transcription of the human beta-globin locus in transgenic mice
Objective. Persistent expression of the human fetal gamma-globin genes
in the adult stage is often associated with naturally occurring
deletions in the human beta-globin locus. The mapping of the 5’
breakpoints of these deletions within the (A)gamma- to delta-globin
intergenic region has suggested that regulatory elements involved in the
silencing of the gamma-globin genes in the adult may be present. We
previously identified two elements in this region, termed Enh and F,
located 3’ to the (A)gamma-globin gene acting as silencers in transient
transfection assays. Here, we tested directly the in vivo significance
of these elements in the developmental regulation of the human beta-like
globin genes. Materials and
Methods. We selectively deleted both Enh and F elements in the context
of a 185-kb human beta-globin locus PAC (P1 phage artificial chromosome)
and tested the effects of this deletion on the expression of the human
beta-like globin genes in transgenic mice.
Results. The Enh/F deletion resulted in an increase in epsilon- and
gamma-globin mRNA levels in the embryonic yolk sac stage of
erythropoiesis, which appears to be due to an increase in the rate of
transcription rather than to an increase in the number of cells
transcribing the human globin locus. However, the human developmental
switching from fetal gamma-globin to adult beta-globin gene expression
in transgenic mice was not affected by this deletion.
Conclusion. These results identify Enh and F as locus-wide regulatory
elements capable of down-regulating transcription of the human
beta-globin locus in an embryonic-specific manner. (C) 2004
International Society for Experimental Hematology. Published by Elsevier
Inc
Identification of a STAT5 Target Gene, Dpf3, Provides Novel Insights in Chronic Lymphocytic Leukemia
STAT5 controls essential cellular functions and is encoded by two genes, Stat5a and Stat5b. To provide insight to the mechanisms linking hematologic malignancy to STAT5 activation/regulation of target genes, we identified STAT5 target genes and focused on Dpf3 gene, which encodes for an epigenetic factor. Dpf3 expression was induced upon IL-3 stimulation in Ba/F3 cells, while strong binding of both STAT5a and STAT5b was detected in its promoter. Reduced expression of Dpf3 was detected in Ba/F3 cells with Stat5a and Stat5b knock-down, suggesting that this gene is positively regulated by STAT5, upon IL-3 stimulation. Furthermore, this gene was significantly up-regulated in CLL patients, where DPF3 gene/protein up-regulation and strong STAT5 binding to the DPF3 promoter, correlated with increased STAT5 activation, mainly in non-malignant myeloid cells (granulocytes). Our findings provide insights in the STAT5 dependent transcriptional regulation of Dpf3, and demonstrate for the first time increased STAT5 activation in granulocytes of CLL patients. Novel routes of investigation are opened to facilitate the understanding of the role of STAT5 activation in the communication between non-malignant myeloid and malignant B-cells, and the functions of STAT5 target genes networks in CLL biology
Persistent Fetal γ-Globin Expression in Adult Transgenic Mice following Deletion of Two Silencer Elements Located 3′ to the Human Aγ-Globin Gene
Natural deletions of the human γ-globin gene cluster lead to specific syndromes characterized by increased production of fetal hemoglobin in adult life and provide a useful model to delineate novel cis-acting elements involved in the developmental control of hemoglobin switching. A hypothesis accounting for these phenotypic features assumes that silencers located within the Aγ-to δ-gene region are deleted in hereditary persistence of fetal hemoglobin (HPFH) and δβ-thalassemias, leading to failure of switching. In the present study, we sought to clarify the in vivo role of two elements, termed Enh and F, located 3′ to the Aγ-globin, in silencing the fetal genes. To this end, we generated three transgenic lines using cosmid constructs containing the full length of the globin locus control region (LCR) linked to the 3.3-kb Aγ-gene lacking both the Enh and F elements. The Enh/F deletion resulted in high levels of Aγ-globin gene expression in adult mice in all single copy lines, whereas, the LCR-Aγ single copy lines which retain the Enh and F elements exhibited complete normal switching of the fetal Aγ-gene. Our study documents directly for the first time the in vivo role of these two gene-proximal negative regulatory elements in silencing the fetal globin gene in the perinatal period, and thus these data may permit their eventual exploitation in therapeutic approaches for thalassemias
Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting carriers of premutation forms of the FMR1 gene, resulting in a progressive development of tremor, ataxia and neuropsychological problems. The disease is caused by an expanded CGG repeat in the FMR1 gene, leading to an RNA gain-of-function toxicity mechanism. In order to study the pathogenesis of FXTAS, new inducible transgenic mouse models have been developed that expresses either 11CGGs or 90CGGs at the RNA level under control of a Tet-On promoter. When bred to an hnRNP-rtTA driver line, doxycycline (dox) induced expression of the transgene could be found in almost all tissues. Dox exposure resulted in loss of weight and death within 5 d for the 90CGG RNA expressing mice. Immunohistochemical examination of tissues of these mice revealed steatosis and apoptosis in the liver. Decreased expression of GPX1 and increased expression of cytochrome C is found. These effects were not seen in mice expressing a normal sized 11CGG repeat. In conclusion, we were able to show in vivo that expression of an expanded CGG-repeat rather than overexpression of a normal CGG-repeat causes pathology. In addition, we have shown that expanded CGG RNA expression can cause mitochondrial dysfunction by regulating expression levels of several markers. Although FTXAS patients do not display liver abnormalities, our findings contribute to understanding of the molecular mechanisms underlying toxicity of CGG repeat RNA expression in an animal model. In addition, the dox inducible mouse lines offer new opportunities to study therapeutic interventions for FXTAS